Cardiovascular Diseases Research in New Mexico
Cardiovascular Diseases Research (93.837) awarded $14.3 million to recipients in New Mexico in 13 grants from fiscal 2021 to 2025, 0.1% of the program's national total. University of New Mexico received the most, $9.8 million.
- Awarded in New Mexico$14.3 million
- Awards13
- Share of the program0.1%
- Rank among states42nd of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.2 million |
| FY 2022 | 8 | $2.9 million |
| FY 2023 | 8 | $3.5 million |
| FY 2024 | 7 | $2.8 million |
| FY 2025 | 9 | $3.9 million |
Recipients in New Mexico
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of New Mexico | Colleges and universities | 11 | $9.8 million |
| Lovelace Biomedical Research Institute | Nonprofits | 1 | $2.8 million |
| Nob Hill Therapeutics, Inc. | Small businesses | 1 | $1.7 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to New Mexico?
$14.3 million from fiscal 2021 to 2025, across 13 awards. New Mexico ranks 42nd of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in New Mexico?
The largest recipient is University of New Mexico, with $9.8 million in 11 awards. Next are Lovelace Biomedical Research Institute and Nob Hill Therapeutics, Inc..
Can organizations in New Mexico apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in New Mexico
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Temporary Assistance for Needy Families
- Children's Health Insurance Program